Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T15:10:50.438Z.
Calculation as of: 2026-10-06T15:10:50.438Z.
Quote observation: 2026-10-06T15:10:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 92e82853ec35d591c91e1857ba5f245e9338475f566e1ab86be3b7c1b83139db
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2025-05-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
N/A
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$356.23M
PS Ratio
6.02
TTM Avg
6.19
3Y Avg
8.23
5Y Avg
116.26
Market Cap
$357.37M
PS Ratio
5.48
TTM Avg
5.21
3Y Avg
3.68
5Y Avg
6.70
Market Cap
$359.28M
PS Ratio
11.24
TTM Avg
35.92
3Y Avg
58.08
5Y Avg
171.51
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | $346.15M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $353.21M | 0.35 | 0.45 | 0.65 | 0.90 |
| Agenus Inc. (AGEN)vs › | $337.72M | 2.55 | 1.38 | 1.35 | 2.67 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.23M | 6.02 | 6.19 | 8.23 | 116.26 |
| Opus Genetics, Inc. (IRD)vs › | $356.23M | 36.14 | 117.36 | 59.63 | 59.63 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.37M | 5.48 | 5.21 | 3.68 | 6.70 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $359.28M | 11.24 | 35.92 | 58.08 | 171.51 |
| Ocugen, Inc. (OCGN)vs › | $359.46M | 78.48 | 97.42 | 62.47 | 82.92 |
| Cabaletta Bio, Inc. (CABA)vs › | $330.92M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.79M | 7.82 | 11.34 | 10.16 | 11.34 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-10 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2025-05-08 | 211.60 |
| 2025-05-07 | 203.83 |
| 2025-05-06 | 186.36 |
| 2025-05-05 | 214.51 |
| 2025-05-02 | 236.84 |
| 2025-05-01 | 230.04 |
| 2025-04-30 | 231.98 |
| 2025-04-29 | 237.81 |
| 2025-04-28 | 237.81 |
| 2025-04-25 | 239.75 |
| 2025-04-24 | 237.81 |
| 2025-04-23 | 237.81 |
| 2025-04-22 | 237.81 |
| 2025-04-21 | 232.95 |
| 2025-04-17 | 217.42 |
| 2025-04-16 | 223.25 |
| 2025-04-15 | 228.10 |
| 2025-04-14 | 190.25 |
| 2025-04-11 | 192.19 |
| 2025-04-10 | 178.60 |
| 2025-04-09 | 193.16 |
| 2025-04-08 | 186.36 |
| 2025-04-07 | 321.28 |
| 2025-04-04 | 236.84 |
| 2025-04-03 | 246.54 |
| 2025-04-02 | 277.60 |
| 2025-04-01 | 291.19 |
| 2025-03-31 | 291.19 |
| 2025-03-28 | 306.72 |
| 2025-03-27 | 343.61 |
| 2025-03-26 | 353.31 |
| 2025-03-25 | 387.29 |
| 2025-03-24 | 36.51 |
| 2025-03-21 | 39.87 |
| 2025-03-20 | 37.72 |
| 2025-03-19 | 41.46 |
| 2025-03-18 | 47.25 |
| 2025-03-17 | 54.81 |
| 2025-03-14 | 47.62 |
| 2025-03-13 | 52.29 |
| 2025-03-12 | 58.36 |
| 2025-03-11 | 55.09 |
| 2025-03-10 | 49.58 |
| 2025-03-07 | 50.05 |
| 2025-03-06 | 47.62 |
| 2025-03-05 | 41.93 |
| 2025-03-04 | 40.99 |
| 2025-03-03 | 36.60 |
| 2025-02-28 | 38.75 |
| 2025-02-27 | 34.83 |
| 2025-02-26 | 36.04 |
| 2025-02-25 | 35.11 |
| 2025-02-24 | 35.20 |
| 2025-02-21 | 35.20 |
| 2025-02-20 | 35.39 |
| 2025-02-19 | 37.54 |
| 2025-02-18 | 38.28 |
| 2025-02-14 | 41.46 |
| 2025-02-13 | 37.44 |
| 2025-02-12 | 34.36 |
| 2025-02-11 | 34.74 |
| 2025-02-10 | 37.72 |
| 2025-02-07 | 36.51 |
| 2025-02-06 | 42.95 |
| 2025-02-05 | 45.57 |
| 2025-02-04 | 44.91 |
| 2025-02-03 | 45.66 |
| 2025-01-31 | 47.44 |
| 2025-01-30 | 50.42 |
| 2025-01-29 | 50.24 |
| 2025-01-28 | 51.92 |
| 2025-01-27 | 55.56 |
| 2025-01-24 | 55.37 |
| 2025-01-23 | 58.36 |
| 2025-01-22 | 61.16 |
| 2025-01-21 | 66.02 |
| 2025-01-17 | 60.97 |
| 2025-01-16 | 63.31 |
| 2025-01-15 | 66.48 |
| 2025-01-14 | 65.08 |
| 2025-01-13 | 71.53 |
| 2025-01-10 | 87.31 |
| 2025-01-08 | 95.80 |
| 2025-01-07 | 98.79 |
| 2025-01-06 | 98.98 |
| 2025-01-03 | 99.63 |
| 2025-01-02 | 93.10 |
| 2024-12-31 | 94.12 |
| 2024-12-30 | 98.79 |
| 2024-12-27 | 99.35 |
| 2024-12-26 | 98.33 |
| 2024-12-24 | 102.34 |
| 2024-12-23 | 97.86 |
| 2024-12-20 | 103.74 |
| 2024-12-19 | 93.38 |
| 2024-12-18 | 93.10 |
| 2024-12-17 | 103.09 |
| 2024-12-16 | 97.11 |
| 2024-12-13 | 99.17 |
| 2024-12-12 | 99.73 |
| 2024-12-11 | 108.69 |
| 2024-12-10 | 114.76 |
| 2024-12-09 | 109.90 |
| 2024-12-06 | 110.18 |
| 2024-12-05 | 108.32 |
| 2024-12-04 | 118.77 |
| 2024-12-03 | 117.75 |
| 2024-12-02 | 119.05 |
| 2024-11-29 | 119.33 |
| 2024-11-27 | 117.65 |
| 2024-11-26 | 114.01 |
| 2024-11-25 | 110.28 |
| 2024-11-22 | 104.58 |
| 2024-11-21 | 101.55 |
| 2024-11-20 | 102.34 |
| 2024-11-19 | 105.52 |
| 2024-11-18 | 96.27 |
| 2024-11-15 | 93.94 |
| 2024-11-14 | 98.14 |
| 2024-11-13 | 109.25 |
| 2024-11-12 | 10.40 |
| 2024-11-11 | 10.65 |
| 2024-11-08 | 10.43 |
| 2024-11-07 | 11.11 |
| 2024-11-06 | 11.51 |
| 2024-11-05 | 9.47 |
| 2024-11-04 | 8.90 |
| 2024-11-01 | 8.53 |
| 2024-10-31 | 8.07 |
| 2024-10-30 | 8.08 |
| 2024-10-29 | 8.64 |
| 2024-10-28 | 8.44 |
| 2024-10-25 | 8.32 |
| 2024-10-24 | 8.08 |
| 2024-10-23 | 8.71 |
| 2024-10-22 | 8.99 |
| 2024-10-21 | 8.34 |
| 2024-10-18 | 9.68 |
| 2024-10-17 | 10.17 |
| 2024-10-16 | 10.82 |
| 2024-10-15 | 10.00 |
| 2024-10-14 | 11.37 |
| 2024-10-11 | 12.02 |
| 2024-10-10 | 11.26 |
| 2024-10-09 | 11.79 |
| 2024-10-08 | 11.82 |
| 2024-10-07 | 11.55 |
| 2024-10-04 | 12.60 |
| 2024-10-03 | 12.25 |
| 2024-10-02 | 12.51 |
| 2024-10-01 | 12.27 |
| 2024-09-30 | 12.29 |
| 2024-09-27 | 11.15 |
| 2024-09-26 | 10.60 |
| 2024-09-25 | 12.02 |
| 2024-09-24 | 10.20 |
| 2024-09-23 | 9.99 |
| 2024-09-20 | 9.92 |
| 2024-09-19 | 9.33 |
| 2024-09-18 | 9.47 |
| 2024-09-17 | 8.71 |
| 2024-09-16 | 7.80 |
| 2024-09-13 | 7.93 |
| 2024-09-12 | 8.55 |
| 2024-09-11 | 9.17 |
| 2024-09-10 | 9.38 |
| 2024-09-09 | 9.55 |
| 2024-09-06 | 9.57 |
| 2024-09-05 | 9.48 |
| 2024-09-04 | 9.06 |
| 2024-09-03 | 8.76 |
| 2024-08-30 | 9.18 |
| 2024-08-29 | 6.07 |
| 2024-08-28 | 5.87 |
| 2024-08-27 | 5.73 |
| 2024-08-26 | 5.78 |
| 2024-08-23 | 5.37 |
| 2024-08-22 | 5.35 |
| 2024-08-21 | 5.41 |
| 2024-08-20 | 5.42 |
| 2024-08-19 | 5.59 |
| 2024-08-16 | 6.28 |
| 2024-08-15 | 6.10 |
| 2024-08-14 | 6.14 |
| 2024-08-13 | 6.01 |
| 2024-08-12 | 6.02 |
| 2024-08-09 | 6.07 |
| 2024-08-08 | 5.91 |
| 2024-08-07 | 6.07 |
| 2024-08-06 | 5.95 |
| 2024-08-05 | 5.96 |
| 2024-08-02 | 6.28 |
| 2024-08-01 | 6.22 |
| 2024-07-31 | 6.33 |
| 2024-07-30 | 6.26 |
| 2024-07-29 | 6.38 |
| 2024-07-26 | 6.44 |
| 2024-07-25 | 6.39 |
| 2024-07-24 | 6.33 |
| 2024-07-23 | 6.45 |
| 2024-07-22 | 6.32 |
| 2024-07-19 | 6.44 |
